.RESEARCH FEATURE.06 August 2024.
A large randomized regulated test with cisgender ladies highlights the problems of faithfulness to a daily oral preexposure prophylaxis program and also demonstrates that twice-yearly shot of lenacapavir can maintain effective HIV deterrence levels over 6 months.